Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 18;15(20):4412.
doi: 10.3390/nu15204412.

Dose-Dependent Beneficial Effect of Ketone Supplement-Evoked Ketosis on Anxiety Level in Female WAG/Rij Rats: Sometimes Less Is More

Affiliations

Dose-Dependent Beneficial Effect of Ketone Supplement-Evoked Ketosis on Anxiety Level in Female WAG/Rij Rats: Sometimes Less Is More

Enikő Rauch et al. Nutrients. .

Abstract

While one-third of the population can be affected by anxiety disorders during their lifetime, our knowledge of the pathophysiology of these disorders is far from complete. Previously, it has been demonstrated in male animals that exogenous ketone supplement-evoked ketosis can decrease anxiety levels in preclinical rodent models, such as Wistar Albino Glaxo/Rijswijk (WAG/Rij) rats. Thus, in this study, we investigated whether intragastric gavage of the exogenous ketone supplement KEMCT (mix of 1,3-butanediol-acetoacetate diester/ketone ester/KE and medium-chain triglyceride/MCT oil in 1:1 ratio) for 7 days can alter the anxiety levels of female WAG/Rij rats using the light-dark box (LDB) test. We demonstrated that a lower dose of KEMCT (3 g/kg/day) increased blood R-βHB (R-β-hydroxybutyrate) levels and significantly decreased anxiety levels (e.g., increased the time spent in the light compartment) in female WAG/Rij rats on the seventh day of administration. Although the higher KEMCT dose (5 g/kg/day) increased blood R-βHB levels more effectively, compared with the lower KEMCT dose, anxiety levels did not improve significantly. We conclude that ketone supplementation might be an effective strategy to induce anxiolytic effects not only in male but also in female WAG/Rij rats. However, these results suggest that the optimal level may be moderately, not highly, elevated blood R-βHB levels when the goal is to alleviate symptoms of anxiety. More studies are needed to understand the exact mechanism of action of ketone supplementation on anxiety levels and to investigate their use in other animal models and humans for the treatment of anxiety disorders and other mental health conditions.

Keywords: LDB test; anxiety; exogenous ketone supplement; female WAG/Rij rat; mental health.

PubMed Disclaimer

Conflict of interest statement

Patent US10980764B1 C. Ari, D.P. D`Agostino, “Exogenous ketone supplements for reducing anxiety-related behavior”. C. Ari is co-owner of Ketone Technologies LLC and owner of Fortis World LLC. These interests have been reviewed and managed by the University in accordance with its Institutional and Individual Conflict of Interest policies. All authors declare that there are no additional conflicts of interest.

Figures

Figure 1
Figure 1
Effect of low KEMCT dose (3 g/kg/day; group 2) and high KEMCT dose (5 g/kg/day; group 3) on anxiety levels (A,B), blood R-βHB (C) and glucose levels (D), as well as body weight (E) compared with baseline (E), water-gavaged animals (control, group 1) (A,B) or both of them (baseline and control; C,D). Abbreviations: Bas, baseline; co., compartment; KEMCT, mix of ketone ester (1,3-butanediol-acetoacetate diester/KE) and medium-chain triglyceride (MCT) oil in 1:1 ratio; R-βHB, R-beta-hydroxybutyrate; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.

Similar articles

Cited by

References

    1. Bandelow B., Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin. Neurosci. 2015;17:327–335. doi: 10.31887/DCNS.2015.17.3/bbandelow. - DOI - PMC - PubMed
    1. Koskinen M.K., Hovatta I. Genetic insights into the neurobiology of anxiety. Trends Neurosci. 2023;46:318–331. doi: 10.1016/j.tins.2023.01.007. - DOI - PubMed
    1. Omori N.E., Malys M.K., Woo G., Mansor L. Exploring the role of ketone bodies in the diagnosis and treatment of psychiatric disorders. Front. Psychiatry. 2023;14:1142682. doi: 10.3389/fpsyt.2023.1142682. - DOI - PMC - PubMed
    1. Dias B.G., Banerjee S.B., Goodman J.V., Ressler K.J. Towards new approaches to disorders of fear and anxiety. Curr. Opin. Neurobiol. 2013;23:346–352. doi: 10.1016/j.conb.2013.01.013. - DOI - PMC - PubMed
    1. Jain N., Kemp N., Adeyemo O., Buchanan P., Stone T.W. Anxiolytic activity of adenosine receptor activation in mice. Br. J. Pharmacol. 1995;1116:2127–2133. doi: 10.1111/j.1476-5381.1995.tb16421.x. - DOI - PMC - PubMed

LinkOut - more resources